NASDAQ 
Dental and medical products company Henry Schein (NASDAQ:HSIC) missed Wall Street’s revenue...
Henry Schein, Inc. (NASDAQ:HSIC – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eleven ratings firms that are covering the firm, Marketbeat Ratings reports ...
Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 ...
HENRY SCHEIN INC has an Investment Rating of HOLD; a target price of $77.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength ...
Henry Schein, Inc. (NASDAQ:HSIC), a global provider of health care solutions with a market capitalization of $8.77 billion and annual revenue of $12.67 billion, has finalized a $250 million ...
Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say...
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the dental equipment &...
Henry Schein One today announced the launch of The 2025 Catalyst Index, its exclusive report offering dental practices an unparalleled view into the strategies transforming performance across ...
Long before the players became gentlemanly private equity titans and activist investors, they were...
